Login / Signup

Epstein-Barr virus-positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma.

Eric TseRex Au-YeungDavid ChauYu-Yan HwangFlorence LoongYok Lam Kwong
Published in: Annals of hematology (2021)
Keyphrases
  • hodgkin lymphoma
  • diffuse large b cell lymphoma
  • epstein barr virus
  • combination therapy
  • replacement therapy